Authors:Conrad Chan; Vanessa Prozzo, Sadaf Aghevlian Raymond M. Reilly Abstract: 111In[In]-BnDTPA-trastuzumab-NLS is a radiopharmaceutical with theranostic applications for imaging and Meitner-Auger electron (MAE) radioimmunotherapy (RIT) of HER2-positive breast cancer (BC). Nuclear localizat... PubDate: 2022-12-21T00:00:00Z
Authors:Dmitry Soloviev; Piotr Dzien, Agata Mackintosh, Gaurav Malviya, Gavin Brown David Lewis Abstract: Sodium iodide symporter (NIS) imaging by positron emission tomography (PET) is gaining traction in nuclear medicine, with an increasing number of human studies being published using fluorine-18 radiolabelled t... PubDate: 2022-12-13T00:00:00Z
Authors:Scott W. McNeil; Michiel Van de Voorde, Chengcheng Zhang, Maarten Ooms, François Bénard, Valery Radchenko Hua Yang Abstract: 161Tb is a radiolanthanide with the potential to replace 177Lu in targeted radionuclide therapy. 161Tb is produced via the neutron irradiation of [160Gd]Gd2O3 targets, and must be purified from 160Gd and the deca... PubDate: 2022-12-02T00:00:00Z
Authors:Kurtulus Eryilmaz; Benan Kilbas Abstract: [18F]Flurpiridaz is a promising novel cardiac PET imaging tracer formed by the radiolabeling of pyridaben derivative with fluorine-18. Clinical studies on [18F]Flurpiridaz are currently at the phase III level for... PubDate: 2022-11-05T00:00:00Z
Open Access journal
